mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |